Afrand Kamali

Afrand Kamali is a highly experienced scientist with a focus on bioanalysis, metabolomics, and drug metabolism. Currently serving as a Senior Scientist at Novo Nordisk since July 2023, Kamali previously held positions including Associate Director and Bioanalysis Team Lead at Synlogic, Inc. and Principal Scientist at Senda Biosciences, where leadership roles encompassed discovery bioanalysis and metabolomics. Additional experience includes senior roles at Kintai Therapeutics and a Scientist position at Takeda Oncology, emphasizing mass spectrometry in biotransformations. Afrand Kamali earned a PhD in Chemistry from Michigan State University, a Master's from Western Michigan University, and a Bachelor's from Sharif University of Technology, complemented by substantial research expertise developed during an earlier role as a Research Assistant.